Difference between revisions of "Team:Tuebingen/Basic Part"
| Line 136: | Line 136: | ||
grid-template-rows: auto; | grid-template-rows: auto; | ||
margin-bottom: 5em; | margin-bottom: 5em; | ||
| − | margin-top: - | + | margin-top: -25em; |
} | } | ||
| Line 323: | Line 323: | ||
| − | |||
| Line 329: | Line 328: | ||
<div id="ImpressumSponsoren"> | <div id="ImpressumSponsoren"> | ||
| − | <img src="https://static.igem.org/mediawiki/2017/5/58/T%C3%BCbingen_Qiagen-Logo.jpeg" id="Quiagen" width= | + | <img src="https://static.igem.org/mediawiki/2017/5/58/T%C3%BCbingen_Qiagen-Logo.jpeg" id="Quiagen" width=70px> <img src="https://static.igem.org/mediawiki/2017/1/1c/T%C3%BCbingen_Roth-Logo.jpeg" id="Roth" width=70px> <img src="https://static.igem.org/mediawiki/2017/d/d8/TuebingenZymoLogo.jpeg" width=150px> <img src="https://static.igem.org/mediawiki/2017/5/5b/T%C3%BCbingen_Eurofins-Logo.png" id="eurofins" width=150px> <img src="https://static.igem.org/mediawiki/2017/e/e4/GATCTuebingen.png" id="GATC" width=150px> <img src="https://static.igem.org/mediawiki/2017/4/49/T%C3%BCbingen_NEB-Logo.jpeg" id="BioLabs" width=150px><br><img src="https://static.igem.org/mediawiki/2017/7/7c/T%C3%BCbingen_Greiner-Logo.jpeg" id="Greiner" width=150px> <img src="https://static.igem.org/mediawiki/2017/b/bf/T%C3%BCbingen_Agilent-Logo.jpeg" id="Agilent" width=150px> <img src="https://static.igem.org/mediawiki/2017/0/01/T%C3%BCbingen_abcr-Logo.png" id="abcr" width=150px> <img src="https://static.igem.org/mediawiki/2017/5/59/MicrosynthTuebingen.png" width=150px> <img src="https://static.igem.org/mediawiki/2017/8/8b/Eppendorftuebingen.png" width=150px> |
| − | <div> <p> © iGEM Team Tuebingen 2017</p | + | <div> <p> © iGEM Team Tuebingen 2017</p></div> |
</div> | </div> | ||
Revision as of 12:36, 12 December 2017
basic parts
Basic Parts
SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams
CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
The BLS mutant is a rationally designed mutant of the β-lactam synthetase
Gyrase B (GyrB)is a type II topoisomerase
Gyrase B (GyrB)is a type II topoisomerase
© iGEM Team Tuebingen 2017
